期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Clinical correlation of gallstone disease in a Chinese population in Taiwan:Experience at Cheng Hsin General Hospital 被引量:11
1
作者 Chi-Ming Liu Tao-Hsin Tung +7 位作者 Pesus Chou Victor Tze-Kai Chen Chung-Te Hsu Wu-Shyong Chien yeu-tyng lin Hsu-Feng Lu Hui-Chuan Shih Jorn-Hon Liu 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第8期1281-1286,共6页
AIM: TO explore the prevalence of gallstone disease (GSD) in Taiwan and condition-associated factors related to it. METHODS: We studied a total of 2386 healthy adults (1235 males and 1151 females) voluntarily ad... AIM: TO explore the prevalence of gallstone disease (GSD) in Taiwan and condition-associated factors related to it. METHODS: We studied a total of 2386 healthy adults (1235 males and 1151 females) voluntarily admitted to Cheng Hsin General Hospital for a paid physical check-up between January 2002 and December 2002. Blood samples and ultrasound sonography results were collected. RESULTS: The overall prevalence of GSD among this study-population was 5.3%, including 1.7% (n=40) having a single stone, 2.3% (n = 55) having multiple stones, and 1.3% (n = 31) having cholecystectomy. The prevalence revealed a statistically significant increase with increasing age (P〈 0.0001). Females exhibited a greater prevalence of multiple stones than did males (3.0% vs 1.7%, P= 0.04). Using multiple logistic regression analysis, the following appeared to be significantly related to the prevalence of GSD: older age (40-49 years vs 〈40 years, OR= 1.63 [95% CI: 0.76-3.48], 50-59 years vs 〈40 years, OR=4.93 [95% CI: 2.43-9.99], 60-69 years vs 〈40 years, OR = 6.82 [95% CI: 3.19-14.60], ≥70 years vs 〈40 years, OR= 10.65 [95% CI: 4.78-23.73]), higher BMI (≥27 kg/m^2 vs 〈24 kg/m^2, adjusted OR= 1.74 [95% CI: 1.04-2.88]), and higher FPG (≥ 126 mg/dL vs 〈110 mg/dL, OR= 1.71, 95% CI: 1.01-2.96). CONCLUSION: Older age (≥50 years), obesity (BMI ≥ 27 kg/m^2), and type 2 diabetes (FPG ≥126 mg/dL) are associated with the prevalence of GSD. 展开更多
关键词 Cross-sectional study Gallstone disease PREVALENCE Risk factors
下载PDF
Evidence-Based Medicine of Screening of Diabetic Retinopathy among Type 2 Diabetes: A Clinical Overview 被引量:2
2
作者 yeu-tyng lin Yen-Chen Chen +4 位作者 Yu-Ting Peng Lujie Chen Jorn-Hon Liu Fu-Li Chen Tao-Hsin Tung 《Health》 2015年第7期873-883,共11页
Diabetic retinopathy (DR) is a well-characterized chronic ocular disorder that developed in nearly all diabetic patients in the long run. The knowledge of DR is crucial to manage this disorder when planning screening ... Diabetic retinopathy (DR) is a well-characterized chronic ocular disorder that developed in nearly all diabetic patients in the long run. The knowledge of DR is crucial to manage this disorder when planning screening and preventive programs and identifying the appropriated therapeutic strategies among. Expectant management may represent a valid therapeutic approach depending upon the clinical manifestations of the disease and, in particular, on the changes over time. If early treatment of DR reduces the probability of severe stage or slows the progression of blindness, it might sufficiently reduce treatment costs in later years to offset the costs of screening and early treatment. In addition, whether screening for DR is worthwhile is contingent on whether subjects are willing to pay the eye screening program that would decrease the risk of photocoagulation. In this review we discuss epidemiology, management, and economic evaluation of screening of DR among type 2 diabetes. 展开更多
关键词 DIABETIC RETINOPATHY EPIDEMIOLOGY Economic Evaluation SCREENING Type 2 DIABETES
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部